Enoxaparin and glycoprotein IIb/IIIa inhibition in non–ST-elevation acute coronary syndrome
Exploring the role of enoxaparin in the management of high-risk patients with non–ST-elevation acute coronary syndromes
A perspective on trials comparing enoxaparin and unfractionated heparin in the treatment of non–ST-elevation acute coronary syndromes
A contemporary assessment of low-molecular-weight heparin for the treatment of acute coronary syndromes